What one share of Anika Therapeutics holds
Founded in 1992, Anika Therapeutics, Inc. (“Anika” or “Company”) is a global leader in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The Company leverages proprietary hyaluronic acid (“HA”) technology to develop highly differentiated products.
Anika Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $8.68 |
|---|---|
| Profit | −$0.27 |
| Capex (buildings and equipment) | $0.39 |
| Free cash flow | $0.04 |
| Cash and investments | $2.87 |
| Book value | $10.26 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $3.47 | $0.32 | $0.34 | −$0.07 | — | $7.21 |
| 2010 | $4.07 | $0.32 | $0.20 | $0.37 | — | $6.32 |
| 2011 | $4.71 | $0.62 | $0.10 | $0.64 | — | $6.95 |
| 2012 | $4.97 | $0.82 | $0.10 | $0.63 | — | $7.86 |
| 2013 | $5.06 | $1.39 | $0.03 | $1.67 | — | $9.49 |
| 2014 | $6.92 | $2.51 | $0.10 | $2.52 | — | $11.99 |
| 2015 | $6.07 | $2.01 | $0.60 | $2.00 | — | $14.02 |
| 2016 | $6.84 | $2.15 | $0.93 | $0.69 | — | $15.23 |
| 2017 | $7.53 | $2.11 | $0.60 | $2.11 | — | $17.94 |
| 2018 | $7.19 | $1.27 | $0.32 | $2.06 | — | $18.55 |
| 2019 | $7.97 | $1.89 | $0.20 | $2.38 | — | $20.16 |
| 2020 | $9.17 | −$1.69 | $0.11 | $0.80 | — | $19.01 |
| 2021 | $10.10 | $0.28 | $0.35 | $0.22 | — | $19.88 |
| 2022 | $7.70 | −$1.02 | $0.51 | −$0.21 | — | $19.53 |
| 2023 | $8.24 | −$5.64 | $0.37 | −$0.49 | — | $14.48 |
| 2024 | $8.15 | −$3.83 | $0.53 | −$0.16 | — | $10.68 |
| 2025 | $7.87 | −$0.76 | $0.48 | $0.30 | — | $10.33 |
Common questions about Anika Therapeutics
How much does one share of Anika Therapeutics earn?
Over the last 12 months, Anika Therapeutics lost $0.27 for each share on $8.68 of sales.
Does Anika Therapeutics pay a dividend?
Anika Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Anika Therapeutics’s book value per share?
Anika Therapeutics’s book value is $10.26 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Anika Therapeutics have?
Each share of Anika Therapeutics has $2.87 of cash and investments, as of June 30, 2026.
What is Anika Therapeutics’s free cash flow per share?
$0.04 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Anika Therapeutics bought back shares?
Anika Therapeutics’s share count rose about 24% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.